Cleary Gottlieb acted as counsel for Biomet in its $500 million senior secured asset-based revolving credit facility, comprised of a $400 million U.S. Subfacility and a $100 million Euro-equivalent Dutch Subfacility. The new facility replaces Biomet’s 2007 ABL credit facility.
Biomet designs, manufactures and markets a diverse portfolio of reconstructive, fixation and other products used primarily by musculoskeletal medical specialists.
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.